Anhui Huaheng Biotechnology Balance Sheet Health
Financial Health criteria checks 2/6
Anhui Huaheng Biotechnology has a total shareholder equity of CN¥1.9B and total debt of CN¥2.0B, which brings its debt-to-equity ratio to 110.1%. Its total assets and total liabilities are CN¥4.7B and CN¥2.8B respectively. Anhui Huaheng Biotechnology's EBIT is CN¥328.7M making its interest coverage ratio 11.8. It has cash and short-term investments of CN¥445.3M.
Key information
110.1%
Debt to equity ratio
CN¥2.04b
Debt
| Interest coverage ratio | 11.8x |
| Cash | CN¥445.31m |
| Equity | CN¥1.86b |
| Total liabilities | CN¥2.85b |
| Total assets | CN¥4.70b |
Recent financial health updates
Recent updates
Positive Sentiment Still Eludes Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Following 25% Share Price Slump
Jan 17
Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Analysts Just Cut Their EPS Forecasts Substantially
Dec 20Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Soars 35% But It's A Story Of Risk Vs Reward
Oct 21Here's Why We Think Anhui Huaheng Biotechnology (SHSE:688639) Is Well Worth Watching
Oct 14Slammed 29% Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Screens Well Here But There Might Be A Catch
Sep 05Anhui Huaheng Biotechnology's (SHSE:688639) Profits Appear To Have Quality Issues
Sep 03Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Analysts Just Cut Their EPS Forecasts Substantially
Sep 02Many Would Be Envious Of Anhui Huaheng Biotechnology's (SHSE:688639) Excellent Returns On Capital
Aug 20Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jul 22Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Intrinsic Value Is Potentially 43% Above Its Share Price
Jul 12Is Anhui Huaheng Biotechnology (SHSE:688639) Using Too Much Debt?
Jun 21Take Care Before Jumping Onto Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Even Though It's 27% Cheaper
Jun 05We Ran A Stock Scan For Earnings Growth And Anhui Huaheng Biotechnology (SHSE:688639) Passed With Ease
May 12Earnings Report: Anhui Huaheng Biotechnology Co., Ltd. Missed Revenue Estimates By 37%
Apr 23Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Business Is Trailing The Market But Its Shares Aren't
Mar 18Financial Position Analysis
Short Term Liabilities: 688639's short term assets (CN¥1.2B) do not cover its short term liabilities (CN¥2.1B).
Long Term Liabilities: 688639's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥796.8M).
Debt to Equity History and Analysis
Debt Level: 688639's net debt to equity ratio (86.1%) is considered high.
Reducing Debt: 688639's debt to equity ratio has increased from 20.9% to 110.1% over the past 5 years.
Debt Coverage: 688639's debt is not well covered by operating cash flow (1.8%).
Interest Coverage: 688639's interest payments on its debt are well covered by EBIT (11.8x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/16 13:21 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Anhui Huaheng Biotechnology Co., Ltd. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tianhe Wang | China International Capital Corporation Limited |
| Chao Li | Citic Securities Co., Ltd. |
| Lin Yang | Guosen Securities Co., Ltd. |